Metlife Inc (MET)
79.79 x 1 82.14 x 1
Post-market by (Cboe BZX)
81.01 -1.73 (-2.09%) 02/21/25 [NYSE]
79.79 x 1 82.14 x 1
Post-market 81.22 +0.21 (+0.26%) 19:52 ET
for Fri, Feb 21st, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
Sales | 70,986,000 | 66,905,000 | 68,770,000 | 68,696,000 | 67,842,000 |
Total expenses | 65,364,000 | 64,743,000 | 62,406,000 | 60,178,000 | 60,915,000 |
Pre-tax Income | 5,622,000 | 2,162,000 | 6,364,000 | 8,518,000 | 6,927,000 |
Income Tax | 1,178,000 | 560,000 | 1,062,000 | 1,642,000 | 1,509,000 |
Net Income Continuous | 4,444,000 | 1,602,000 | 5,302,000 | 6,876,000 | 5,418,000 |
Minority Interests | 18,000 | 24,000 | 18,000 | 21,000 | 11,000 |
Net Income | $4,426,000 | $1,578,000 | $5,284,000 | $6,855,000 | $5,407,000 |
EPS Basic Continuous Ops | N/A | 2.11 | 6.60 | 7.97 | 5.97 |
EPS Basic Total Ops | N/A | 1.82 | 6.35 | 7.71 | 5.72 |
EPS Diluted Continuous Ops | 6.25 | 2.10 | 6.55 | 7.91 | 5.93 |
EPS Diluted Total Ops | 1.78 | 1.81 | 6.30 | 7.65 | 5.68 |
EPS Diluted Before Non-Recurring Items | 8.11 | 7.33 | 6.85 | 9.15 | 6.16 |
EBITDA(a) | $6,659,000 | $1,548,000 | $6,045,000 | $8,338,000 | $6,730,000 |